Furthermore, in the absence of ERO1α, we observed that PDA cells also displayed substantially reduced expression of the immune inhibitory molecule PD-L1, which is typically upregulated in many different cancer types (Figure 5A). The gene discussed is ERO1A; the disease is Patent ductus arteriosus.